Proceedings | Boulder Peptide Symposium

September 15-18, 2025

LIVE, In Person at the St. Julien Hotel in Boulder, Colorado
The only conference focused solely on the pharmaceutical development of peptide therapeutics.

BPS September 2018


Peptides enabling extended intravitreal drug delivery as nano-particle conjugates

Jack Henkin

Research Professor, Chemistry, Center for Developmental Therapuetics, Northwestern University

ABSTRACT

Short peptides containing 2-4 L-Arg residues were linked to condensed dextran nanoparticles yielding < 100nm carriers with zeta potential from +3 to+9 mV, diffusing very slowly in vitreous humor by IVIS, with promise to to enable controlled intraocular drug delivery.

BIO

BS-Chemistry City College of CUNY, PhD Biochemistry Brandeis University, Jane Coffin Childs Postdoc fellow Harvard, U of Texas Med School faculty 1978-84. Abbott Laboratories Drug Discovery 1984-2011, Outstanding Researcher of 2003 Abbott Labs. Res. Prof. Northwestern University Ctr Dev Therapeut 2013-2018. Current funding National Eye Institute. Coauthor 94 refereed pubs., inventor 12 US patents on peptides and/or angiogenesis. 12 Invited reviews or book chapters. Major interest-peptide therapeutics.


s2Member®
loading...